# VEOPOZ
> **BLA761339** · Biologics License Application · Sponsor: REGENERON PHARMACEUTICALS · Approved 2023-08-18
## Drug
- **FDA Application Number:** BLA761339
- **Application type:** Biologics License Application
- **Brand name:** VEOPOZ
- **Generic name:** POZELIMAB
- **Active ingredients:** POZELIMAB-BBFG
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** REGENERON PHARMACEUTICALS
- **Manufacturer:** Regeneron Pharmaceuticals, Inc.
- **First approval:** 2023-08-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761339)
---
*MORVS · CC0 1.0*